Literature DB >> 3963954

Oxygen saturation with sleep in patients with sickle cell disease.

R J Castele, K P Strohl, C S Chester, G M Brittenham, J W Harris.   

Abstract

Ear oximetry was used to monitor arterial oxygenation in seven patients who had a history of frequent admissions for sickle cell crisis and were taking narcotic analgesics. Five full-night studies and seven daytime "nap" studies were performed in which sleep state was monitored by electroencephalography, and respiratory rate and tidal volume were monitored by inductance plethysmography. For all patients the mean (+/- SEM) of the median oxygenation values was 93.3% +/- 0.4% during wakefulness and 91.4% +/- 0.8% during sleep. During wakefulness the lowest saturation was 90% +/- 0.5%; during sleep there was a fall in the lowest oxygen saturation to 86.5% +/- 0.9%. In all patients a fall in oxygen saturation was associated with a decrease in respiratory depth without a change in respiratory frequency. The results indicate that in sickle cell disease oxygen saturation is lower during sleep than during wakefulness and that hypoxemia can be attributed to a fall in tidal volume.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3963954

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Arterialization of peripheral venous blood in sickle cell disease.

Authors:  Masoud Nahavandi; Richard M Millis; Fatemeh Tavakkoli; Meville Q Wyche; Elliott Perlin; William P Winter; Oswaldo Castro
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

Review 2.  Pulmonary manifestations of sickle cell disease.

Authors:  A K Siddiqui; S Ahmed
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

3.  Sleep related upper airway obstruction and hypoxaemia in sickle cell disease.

Authors:  M P Samuels; V A Stebbens; S C Davies; E Picton-Jones; D P Southall
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 4.  Wheezing in children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Robert Strunk; Michael R DeBaun
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.